|
FAM82A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.797640E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.730810E-01 |
| Normal-vs-Stage2 |
1.974200E-01 |
| Normal-vs-Stage3 |
3.52150000000329E-05 |
| Normal-vs-Stage4 |
3.56360000000056E-05 |
| Stage1-vs-Stage2 |
6.129600E-01 |
| Stage1-vs-Stage3 |
1.409210E-04 |
| Stage1-vs-Stage4 |
1.245770E-04 |
| Stage2-vs-Stage3 |
5.948300E-02 |
| Stage2-vs-Stage4 |
3.915600E-02 |
| Stage3-vs-Stage4 |
6.713800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.983200E-04 |
| Normal-vs-AfricanAmerican |
4.909200E-01 |
| Normal-vs-Asian |
9.945700E-02 |
| Caucasian-vs-AfricanAmerican |
1.074550E-01 |
| Caucasian-vs-Asian |
7.138400E-01 |
| AfricanAmerican-vs-Asian |
3.741600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19059999999605E-05 |
| Normal-vs-Female |
5.479200E-01 |
| Male-vs-Female |
1.76067999999585E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.484760E-03 |
| Normal-vs-Age(41-60Yrs) |
1.536120E-02 |
| Normal-vs-Age(61-80Yrs) |
1.982510E-03 |
| Normal-vs-Age(81-100Yrs) |
3.609600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.232820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.508200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.307000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.961200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.803400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.200200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.372340E-02 |
| Normal-vs-Grade 2 |
1.734200E-01 |
| Normal-vs-Grade 3 |
1.255700E-03 |
| Normal-vs-Grade 4 |
1.59530000320984E-08 |
| Grade 1-vs-Grade 2 |
3.104300E-03 |
| Grade 1-vs-Grade 3 |
5.171300E-04 |
| Grade 1-vs-Grade 4 |
8.37740000037002E-07 |
| Grade 2-vs-Grade 3 |
2.232400E-02 |
| Grade 2-vs-Grade 4 |
5.83529999875765E-08 |
| Grade 3-vs-Grade 4 |
6.577700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.647400E-01 |
| Normal-vs-ccB subtype |
3.36900000008633E-07 |
| ccA subtype-vs-ccB subtype |
9.96060012248279E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.800400E-03 |
| Normal-vs-N1 |
5.79769999999868E-05 |
| N0-vs-N1 |
1.710480E-02 |
|
|
